These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17362994

  • 21. Natalizumab: new drug. Multiple sclerosis: risky market approval.
    Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Assessing disability progression with the Multiple Sclerosis Functional Composite.
    Rudick RA, Polman CH, Cohen JA, Walton MK, Miller AE, Confavreux C, Lublin FD, Hutchinson M, O'Connor PW, Schwid SR, Balcer LJ, Lynn F, Panzara MA, Sandrock AW.
    Mult Scler; 2009 Aug; 15(8):984-97. PubMed ID: 19667023
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Natalizumab treatment in pediatric multiple sclerosis: a case report.
    Borriello G, Prosperini L, Luchetti A, Pozzilli C.
    Eur J Paediatr Neurol; 2009 Jan; 13(1):67-71. PubMed ID: 18406645
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Apolipoprotein alleles and the response to interferon-β-1b in multiple sclerosis.
    Carmona O, Masuet C, Alía P, Moral E, Alonso-Magdalena L, Casado V, Martín-Ozaeta G, Arbizu T.
    Eur Neurol; 2011 Jan; 65(3):132-7. PubMed ID: 21325856
    [Abstract] [Full Text] [Related]

  • 28. Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
    Johnson BH, Bonafede MM, Watson C.
    CNS Drugs; 2015 Jun; 29(6):503-10. PubMed ID: 26113055
    [Abstract] [Full Text] [Related]

  • 29. Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding.
    Ferrero S, Esposito F, Pretta S, Ragni N.
    Expert Rev Neurother; 2006 Dec; 6(12):1823-31. PubMed ID: 17181429
    [Abstract] [Full Text] [Related]

  • 30. Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study.
    Pachner AR, Cadavid D, Wolansky L, Skurnick J.
    Neurology; 2009 Nov 03; 73(18):1485-92. PubMed ID: 19884576
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interferon after 10 years in patients with multiple sclerosis.
    Pozzilli C, Prosperini L, Sbardella E, Paolillo A.
    Neurol Sci; 2006 Sep 03; 27 Suppl 5():S369-72. PubMed ID: 16998723
    [Abstract] [Full Text] [Related]

  • 34. Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis.
    Ytterberg C, Johansson S, Andersson M, Olsson D, Link H, Holmqvist LW, von Koch L.
    Acta Neurol Scand; 2007 Aug 03; 116(2):96-9. PubMed ID: 17661794
    [Abstract] [Full Text] [Related]

  • 35. Adherence to interferon-beta treatment and results of therapy switching.
    Clerico M, Barbero P, Contessa G, Ferrero C, Durelli L.
    J Neurol Sci; 2007 Aug 15; 259(1-2):104-8. PubMed ID: 17376486
    [Abstract] [Full Text] [Related]

  • 36. Measures in the first year of therapy predict the response to interferon beta in MS.
    Río J, Castilló J, Rovira A, Tintoré M, Sastre-Garriga J, Horga A, Nos C, Comabella M, Aymerich X, Montalbán X.
    Mult Scler; 2009 Jul 15; 15(7):848-53. PubMed ID: 19542263
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H, Skoog B, Hillert J, Runmarker B, Stawiarz L, Oluf A.
    Lakartidningen; 2009 Jul 15; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.